Strides Pharma Scien Share Price

Strides Pharma Scien (INR)1638.559.6   (0.6%)

Exchange ScripsBSE532531NSESTARISININE939A01011

Stock Performance
Fundamentals
Technicals
Shareholding Patterns
Financials
Similar Stocks

Trendline of performance -

Strides Pharma Scien Performance

Market performance
Open price1636.25
High1672
Volumes225685
Prev Close1638.55
Low1603.25
Closing date2024-10-21
Historical performance
1 Year High1675.00
3 Year High1675.00
5 Year High1675.00
1 Year Low467.00
3 Year Low263.35
5 Year Low263.35

Strides Pharma Scien Fundamentals

Company Valuation
Market Cap
Market Cap (₹Cr)
14979
Face Value
Face Value (₹)
10
P/E Ratio
P/E Ratio
-213.25
Dividend Yield
Dividend Yield
0.02 %

Strides Pharma Scien Investment Returns

1 Year
229.3%
3 Years
194.1%
5 Years
363.1%
10 Years
151.7%

Strides Pharma Scien Technicals

IndicatorsValueSignal
5-DMA1621.53Bullish
10-DMA1569.78Bullish
20-DMA1486.18Bullish
50-DMA1381.06Bullish
100-DMA1169.54Bullish
200-DMA978.91Bullish

Shareholding Pattern

FieldSep-2024Jun-2024Mar-2024Dec-2023Sep-2023
Promoters1515151616
Foreign Investors---------------
Domestic Investors1515151616
Public Investors95994919028468091166101622
Government11111

Strides Pharma Scien Financials

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023Mar-2022Mar-2021
Other Income49813521334594
Operating Profit7830520511196863
Interest3144261117671501
Depreciation2207243323302063
Profit Before Tax-1169-2862-65252754
Consolidated Net Profit-706-2026-46022684
Adjusted EPS-8-22-5130

Balance Sheet

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023Mar-2022Mar-2021
Share Capital919903898897
Total Reserves20306210252267026823
Minority Interest-539-394241373
Total Non-Current Liabilities621412103965712644
Total Liabilities55724637346760768168
Capital Work in Progress7994835622276
Total Assets55724637346760768168

Cash Flow

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023Mar-2022Mar-2021
Cash Flow from Operating Activities7011444-25784814
Cash Flow from Investing Activities-15023025-1187-5208
Cash Flow from Financing Activitie-6933-21394213-158
Net Cash Inflow / Outflow-14251330448-552
0%
Negative
Neutral
Positive
  • The stock has a PE ratio of -213.25.
  • 3Y Stock Price CAGR of the stock is 44.2.
  • The stock has a beta of 0.6.
  • In the last financial year, the company had an EBITDA of ₹7830 Million.
  • The company generated revenue of ₹40511 Million in the previous financial year.

Strides Pharma Scien

1638.559.6   (0.6%)

Investment Amount: ₹ 48525
Current Value: ₹ 163855
Performence: 237.7%
P/L: ₹ 115330
Top Gainers
SymbolChange%
VHL5303.9(20%)
GFLLIMITED119.34(20%)
DIFFNKG408.3(20%)
SILINV877.1(20%)
PILANIINVS7536.05(20%)
Top Losers
SymbolChange%
PNCINFRA366.8(-20%)
INDIAMART2508.6(-17%)
RBLBANK176.14(-14%)
WABAG1710(-9%)
JMFINANCIL147.05(-7%)
MITCON107.19(-7%)
TATACONSUM1017.05(-7%)
AETHER862.6(-7%)
Similar stocks

RPG Life Sciences

22.3

2749.85

September 21 - October 21

Jagsonpal Pharma

18.8

487.3

September 21 - October 21

Unichem Lab

17.3

757.95

September 21 - October 21

Windlas Biotech

14

1002.95

September 21 - October 21

Ipca Laboratories

12.5

1614.35

September 21 - October 21

Gufic Biosciences

10.9

450.15

September 21 - October 21

Medicamen Biotech

10.9

513.3

September 21 - October 21

Solara Active Pharma

9.7

822.35

September 21 - October 21

Announcing Stock of the Month!

Stock of the Month
Stock of the Month